.....is another Settlement date for short interest in Insmed shares. We will find out what the numbers are on 12/24/13. Would you expect to see some covering today or more shorting?
I was at a Bible Study last night and something that was said really hit me......"how we respond to the Gospel (good news) has consequences both now and later." My prayer is that those here reading this will hear and respond to the Gospel. I know there are some atheists and agnostics here. There's nothing I can say to persuade them to change their minds, unless they are open to hearing it. It's up to them to believe or not. I guess I would only suggest they do what Lee Strobel, author of The Case for Christ, did. He was a Chicago Tribune editor and court writer (and an atheist) who started out to discredit Christ and Christianity. I won't spoil the ending, but everyone should read his book.
Thanks for the reminder, also. Stu. I look forward to meeting you sometime.
1 Peter 1:23
For you have been born again, not of perishable seed, but of imperishable, through the living and enduring word of God.
.....so far this morning. I wonder if the shorts are having some trouble finding shares? I treated myself to an early Christmas present yesterday and bought a few shares. Have a good day everyone.
Got to thinking......could this be some "short covering"? I would imagine a lot of people are taking off for Christmas vacations after today. Maybe they just want to close their position before the end of the year. Can't say that I blame them....8-) Either way, I like to see it.
Yes, Vertex did not meet its' primary endpoint, according to the article......however, the stock was up a little over 2 1/2% today.
Hand, I think we need some clarification. As I type, Insmed's current market cap is 636 million. So, what are you basing Insmed's value at 1 billion? Arikace? iPlex....partnering for which indications? igfbp3? INSM-18? To me INSM has several prongs......so, it's hard to determine a prediction. I have set my personal selling price at $180......but I think I will be getting out early of true potential.
I'll try to do that tomorrow, Hand. The market closes at 1:00 ET......don't know if it will be posted then or after 4:00 ET
As you can see, I am just piddling around on this site waiting for some cookie baking by the ladies to be done so I can sample said cookies....LOL. Question.....any shorts out there can answer, will you be covering your shorts so you can take advantage of declaring your losses for end of year taxes? If so, you just have one more week to do so.
20 Middlesex technology and biotechnology companies are set to each receive an estimated $1.1 million grant, the New Jersey Economic Development Authority announced.
The New Jersey Economic Development Authority (EDA) awarded 54 companies with a share of $60 million in 2014.
This competitive program enables technology and biotechnology companies to sell New Jersey tax losses and/or research and development tax credits to raise cash to finance their growth and operations.
Since the program was established in 1999, more than 490 different businesses have been approved for awards totaling $770 million. Each of the 54 applicants approved this year will receive an estimated $1.1 million which is a 21 percent increase from last year.
"The NOL Program continues to be the most popular and the most effective support for these early stage companies,” said EDA Chief Executive Officer Michele A. Brown in a release. "The Christie Administration understands that the success of the State’s greater technology industry is fundamentally tied to the growth of New Jersey’s economy. These companies have been able to raise capital and build their businesses in New Jersey as a result of this innovative program. This is exactly the kind of vital support this sector needs."
The Middlesex companies include:
•Amicus Therapeutics, Inc.- Biotech - Cranbury
•Blacklight Power, Inc.- Tech- Cranbury
•Palatin Technologies, Inc.- Biotech- Cranbury
•Cornerstone Pharmaceuticals- Biotech- Cranbury
•Oncobiologics Inc.- Biotech - Cranbury
•Replication Medical, Inc.- Biotech - Cranbury
•Vaxinnate Corporation- Biotech - Cranbury
•Savient Pharmaceuticals, Inc. - Biotech- East Brunswick
•Symbolic IO Corporation - Tech- Edison
•CytoSorbents, Inc.- Biotech- Monmouth Junction
•Insmed Incorporated- Biotech- Monmouth Junction
•Rive Technology, Inc.- Tech - Monmouth Junction
•TyRx Pharma, Inc.-Biotech - Monmouth Junction
•Liquid Light- Tech- Monmouth Junction
•Connotate Technologies, Inc.- Tech- New Brunswick
.....DOWN about 16% for settlement date period of 12/13/13
Merry Christmas, ALL
Avg Daily Share Volume
Days To Cover
12/13/2013 3,262,450 373,660 8.731066
11/29/2013 3,861,039 398,584 9.686889